Helios Fairfax Partners (OTCPK:FFXX.F) has put up a mixed set of FY 2025 numbers so far, with third quarter revenue at US$17.4 million and basic EPS of US$0.09, while the trailing 12 month figures still reflect losses on both revenue and EPS. Over recent periods the company has seen quarterly revenue move from US$8.6 million in Q1 2025 to US$17.2 million in Q2 2025 and US$17.4 million in Q3 2025. Basic EPS shifted from US$0.01 in Q1 to US$0.11 in Q2 before landing at US$0.09 in Q3. This gives investors a clearer read on how margins are behaving through the year even as the longer term picture remains loss making.

See our full analysis for Helios Fairfax Partners.

With the headline figures on the table, the next step is to set these results against the most widely held market narratives about Helios Fairfax Partners and see which views the numbers support and which they start to challenge.

US$9.7m profit in Q3 against loss on TTM basis

• For Q3 FY 2025, Helios Fairfax Partners reported net income of US$9.7 million and basic EPS of US$0.09, while on a trailing 12 month view the company still shows a net loss of US$19.5 million and basic EPS of US$0.18 loss.
• What stands out for a bullish view is that three of the last four reported quarters, from Q3 2024 to Q3 2025, show positive net income between US$0.9 million and US$11.6 million. However, the trailing 12 month figures remain in loss territory, which reminds you that recent profitability is still set against a wider period of losses.
  • Supporters can point to the shift from a net loss of US$41.6 million in Q4 2024 to positive net income in each 2025 quarter reported so far as evidence that the business has been operating more profitably in recent quarters.
  • Cautious investors may focus on the trailing 12 month net loss of US$19.5 million and EPS loss of US$0.18 as a sign that the overall period remains loss making despite the recent positive quarters.

Results like this often encourage some investors to zoom out and compare near term profits against the longer trailing losses before deciding how much weight to put on the latest quarter.

Premium 7.4x P/S despite trailing losses

• The shares trade on a P/S of 7.4x while the US Capital Markets industry average is 3.1x and a peer average is 4.5x, so the stock is priced at a higher sales multiple even though the trailing 12 month results are loss making.
• Critics highlight that paying 7.4x sales for a company with a trailing 12 month net loss of US$19.5 million and trailing revenue of US$26.9 million means the current valuation already assumes a lot compared with an industry where peers trade closer to 3x to 5x sales.
  • This bearish angle leans on the contrast between the multi year loss reduction trend of 17.8% per year and the fact that profitability on a trailing 12 month basis has not yet been achieved.
  • Bears also point to recent share price volatility over the past three months as a reason why a high P/S multiple, combined with ongoing losses, can leave the stock sensitive to any weaker than expected financial updates.

For readers, the key question is whether that premium P/S multiple feels justified given the mix of recent profitable quarters and loss making trailing 12 month results.

Loss reduction trend of 17.8% per year

• Over the past five years, reported losses have reduced at an annualized rate of 17.8%, which sits alongside the recent pattern where quarterly net income in 2025 has been positive while the trailing 12 month figures still show a loss.
• What is interesting here is that a more optimistic narrative about improving profitability metrics over several years has to be balanced against the current trailing 12 month loss of US$19.5 million and the lack of explicit earnings or revenue growth forecasts in the data.
  • Supporters of the improving trend may see the move from a trailing 12 month net loss of US$98.1 million in Q3 2024 to US$19.5 million in Q3 2025 as evidence that the company has been steadily closing the gap toward break even.
  • Others may focus more on the fact that no discounted cash flow valuation or explicit forward growth expectations are provided here, so any view on whether that 17.8% annual loss reduction continues rests on how much weight you want to put on the historical pattern alone.

If you want to see how other investors are framing these same numbers into different storylines, it can be helpful to step back from the raw figures and look at the wider range of interpretations in one place, which you can do through the Curious how numbers become stories that shape markets? Explore Community Narratives

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Helios Fairfax Partners's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

With mixed signals across profitability, valuation and loss trends, now is a good time to look through the underlying data yourself and decide how it all stacks up. To round out that view, consider both sides of the story with the 1 key reward and 1 important warning sign.

See What Else Is Out There

Helios Fairfax Partners still carries a trailing 12 month net loss of US$19.5 million and trades on a premium 7.4x P/S despite those losses.

If that mix of ongoing losses and a rich sales multiple makes you cautious, compare it with companies screened as 62 high quality undervalued stocks to see where the risk reward balance might look more appealing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.